ROCK1 and cardiac hypertrophy: Global homozygous ROCK1–/– (Zhang et al. 2006) and heterozygous ROCK1+/– (Rikitake et al. 2005) mice show beneficial effects such as decreased cardiac fibrosis without affecting pressure overload or angiotensin II-induced cardiac hypertrophy.